CRE Review Report: Kreslake
Aug 29, 2010
CRE continues to review reports identified by FDA in the menthol proceeding.
CRE has previously completed analyses of several other studies and the results are published in this Forum.
Attached hereto is the CRE analysis of the following study:TPSAC Kreslake
CRE is approaching a review of nearly half of the studies identified by FDA regarding smoking iniatation/cessesation.
